Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ADIL

Adial Pharmaceuticals, Inc.

Healthcare · USD

Set alert

Price alert · ADIL

All alert types
5.05 USD +1.34 +36.12%
As of Oct 28, 2026 Extended hours 4.86 -3.76%
Bid
5.04 × 2
Ask
5.14 × 18
3.82 Day range 5.15
4.88 52-week range 5.05
YTD
0.00%
1 year
0.00%
Open
3.83
Prev close
3.71
Mkt cap
13.26M
Vol
83.08K
Avg vol
57.15K
EPS
-20.65
P/E
0.00
Div yield
0.00%
More statistics
Low
3.82
High
5.15
Forward P/E
-0.79
Beta
1.30
Short ratio
0.65
Inst. own
3.03%
Dividend
0.00
Ex-div date
Earnings
Aug 13, 2024
50-d avg
1.06
200-d avg
1.23
1y target
7.50

5D chart

Chart tools
Interval
1m5m15m30m
ADIL five-day price chart3.593.984.374.765.15Oct 26Oct 27Oct 28

Financial health

Altman Z-Score

-12.23 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -0.5×
FY 2016: -46.0×FY 2017: -19.5×FY 2018: -2.1×FY 2019: -2.8×FY 2020: -2.0×FY 2021: -2.6×FY 2022: -0.5×FY 2023: -0.3×FY 2024: -1.4×FY 2025: -0.5×
FY 2016 5y median -0.5× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.7×
FY 2016: -187×FY 2017: -22.2×FY 2018: 5.5×FY 2019: 3.3×FY 2020: 5.3×FY 2021: 14.3×FY 2022: 1.8×FY 2023: 0.6×FY 2024: 4.6×FY 2025: 0.7×
FY 2016 5y median 1.8× FY 2025
P/FCF -0.6×
FY 2016: -70.5×FY 2017: -44.8×FY 2018: -9.8×FY 2019: -3.7×FY 2020: -2.8×FY 2021: -4.2×FY 2022: -0.5×FY 2023: 0.0×FY 2024: -2.7×FY 2025: -0.6×
FY 2016 5y median -0.6× FY 2025
EV/EBITDA 0.3×
FY 2016: -47.6×FY 2017: -23.0×FY 2018: -2.9×FY 2019: -2.0×FY 2020: -1.5×FY 2021: -2.5×FY 2022: -0.2×FY 2023: 0.0×FY 2024: -1.1×FY 2025: 0.3×
FY 2016 5y median -0.2× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -176.6%
FY 2016: -1.4%FY 2017: -2.2%FY 2018: -10.3%FY 2019: -26.7%FY 2020: -36.0%FY 2021: -23.9%FY 2022: -191.3%FY 2023: 0.0%FY 2024: -36.9%FY 2025: -176.6%
FY 2016 5y median -36.9% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -151.2%
FY 2016: 406.0%FY 2017: 114.2%FY 2018: -261.9%FY 2019: -120.3%FY 2020: -272.5%FY 2021: -553.7%FY 2022: -388.6%FY 2023: -171.5%FY 2024: -324.4%FY 2025: -151.2%
FY 2016 5y median -324.4% FY 2025
ROIC -144.4%
FY 2016: -314.2%FY 2017: 322.8%FY 2018: -157.3%FY 2019: -115.5%FY 2020: -273.3%FY 2021: -386.9%FY 2022: -271.6%FY 2023: -168.7%FY 2024: -203.6%FY 2025: -144.4%
FY 2016 5y median -203.6% FY 2025
ROA -117.3%
FY 2016: -277.3%FY 2017: -3298.4%FY 2018: -247.5%FY 2019: -111.9%FY 2020: -197.8%FY 2021: -254.4%FY 2022: -222.1%FY 2023: -147.8%FY 2024: -261.6%FY 2025: -117.3%
FY 2016 5y median -222.1% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 5.9%
FY 2016: 49.9%FY 2017: -142.3%FY 2018: -602.0%FY 2019: -18.0%FY 2020: -32.5%FY 2021: -76.5%FY 2022: 43.7%FY 2023: 36.6%FY 2024: -20.3%FY 2025: 5.9%
FY 2016 FY 2025
EPS (diluted) 32.8%
FY 2016: 48.6%FY 2017: -136.4%FY 2018: -1075.0%FY 2019: 64.3%FY 2020: 0.0%FY 2021: -19.9%FY 2022: 54.1%FY 2023: 54.6%FY 2024: 86.9%FY 2025: 32.8%
FY 2016 FY 2025
Free Cash Flow 6.2%
FY 2016: 41.0%FY 2017: -80.4%FY 2018: -404.9%FY 2019: -153.7%FY 2020: -20.4%FY 2021: -57.4%FY 2022: 6.9%FY 2023: 100.0%FY 2024: 0.0%FY 2025: 6.2%
FY 2016 FY 2025

Financial Health

Current Ratio 4.4×
FY 2016: 0.6×FY 2017: 0.0×FY 2018: 18.2×FY 2019: 14.2×FY 2020: 3.4×FY 2021: 2.4×FY 2022: 2.7×FY 2023: 4.9×FY 2024: 4.2×FY 2025: 4.4×
FY 2016 5y median 4.2× FY 2025
Quick Ratio 4.4×
FY 2016: 0.6×FY 2017: 0.0×FY 2018: 18.2×FY 2019: 14.2×FY 2020: 3.4×FY 2021: 2.4×FY 2022: 2.7×FY 2023: 4.9×FY 2024: 4.2×FY 2025: 4.4×
FY 2016 5y median 4.2× FY 2025
Debt / Equity 0.0×
FY 2016: -2.3×FY 2017: -0.7×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.7×
FY 2016: -0.4×FY 2017: -0.7×FY 2018: 0.6×FY 2019: 0.8×FY 2020: 0.4×FY 2021: 0.3×FY 2022: 0.4×FY 2023: 0.4×FY 2024: 0.3×FY 2025: 0.7×
FY 2016 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2016: -42.6×FY 2017: -6.9×FY 2018: -6.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31